Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like Roivant Licenses Diabetes Drug From Ligand Pharma March 6, 2018 Sangamo, Pfizer Deepen Relationship With New $162M ALS R&D Pact January 2, 2018 Sweden's Lipigon Inks $100 Million Pact with Drug Giant AstraZeneca PLC to Identify New Cholesterol Drugs April 11, 2016
Sweden's Lipigon Inks $100 Million Pact with Drug Giant AstraZeneca PLC to Identify New Cholesterol Drugs April 11, 2016
